1 Nanomedicine: working towards defining the field.- 2
Complement regulators and inhibitors in health and disease: A
structural perspective.- 3 The art of complement: complement
sensing of nanoparticles and consequences.- 4 The nanoscience
of polyvalent binding by proteins in the immune response .- 5
Microfluidics-based Single Cell Analytical Platforms for
Characterization of Cancer.- 6 Nanotheranostics and in-vivo
imaging.- 7 Targeting cancer using nanocarriers.- 8 The
importance of particle geometry in design of therapeutic and
imaging nanovectors.- 9 Delivery of peptides and proteins to
the brain using nano-drug delivery systems and other
formulations.- 10 Polymer-based DNA delivery systems for
cancer immunotherapy.- 11 The use of silk in nanomedicine
applications.- 12 Nanotoxicology and regulatory
affairs.- 13 The application of nanotechnology for implant
drug release.- 14 Guided cellular responses by surface cues
for nanomedicine applications
Kenneth Alan Howard is an Associate Professor and Group Leader at
the Department of Molecular Biology at the Interdisciplinary
Nanoscience Center (iNANO), Aarhus University, Denmark. His
research and teaching activities are focused on delivery science,
nanomedicine and RNA interference. Kenneth Alan Howard received a
PhD in Pharmaceutical Science from the University of Nottingham,
UK, and has held postdoctoral positions at the CRC Institute for
Cancer Studies, University of Birmingham, UK and the School of
Pharmacy, University of London. Dr Howard is an active member of
the Controlled Release Society serving on the Board of Scientific
Advisors (chair), Nominations Committee and organizer of a CRS
Educational workshops “RNA Interference Biology and Therapeutics”
and “Albumin: the next generation therapeutic. Dan Peer is a
translational scientist and Professor that leads an NIH-funded lab
in the Faculty of Life Science and the Faculty of Engineering at
Tel Aviv University (TAU). He is also the Director of the Focal
Technology Area (FTA) on Nanomedicines for Personalized
Theranostics, a National Nanotechnology Initiative and the Director
of the Leona M. and Harry B. Helmsley Nanotechnology Research Fund.
Prof. Peer’s work was among the first to demonstrate systemic
delivery of RNAi molecules using targeted nanocarriers to the
immune system and he pioneered the use of RNA interference (RNAi)
for in vivo validation of new drug targets within the immune
system. He is an editor of several books in the field of
nanomedicine, Editor of Molecular and Cellular Therapies
(Springer); Editor of Biology and Medicine in Nanotechnology (IOP),
an Associate Editor of the Journal of Controlled Release
(Elsevier); Journal of Biomedical Nanotechnology, and of
Biochemistry, and on the Editorial Boards of the Biomedical
Microdevices (Springer), Cancer Letters (Elsevier), Nanomedicine:
Nanotechnology, Biology and Medicine (Elsevier) and Bioconjugate
Chemistry (ACS). Prof. Peer is currently the President of the
Israeli Chapter of the Controlled Release Society, and a Member of
the Israel Young Academy of Sciences and Humanities.
Thomas Vorup-Jensen is head of the Biophysical Immunology
Laboratory in Department of Biomedicine and a member of the iNANO
at Aarhus University. He received a PhD in medicine from Aarhus
University on topics involving the discovery, characterization and
recombinant manufacture of molecules of the complement system. More
recently, he was awarded from the same institution the Doctor of
Medical Science degree following a dissertation on polyvalent
interactions between molecules of the immune system and their
targets, which includes certain nanomedicines. Following his work
as Research Fellow in Pathology with Harvard Medical School and
later employment with Aarhus University, his research has focused
on understanding the nanoscience of protein ligand recognition. In
addition to his academic efforts, Prof. Vorup-Jensen and his
laboratory actively collaborate with industry partners to translate
scientific findings into new treatments of clinical unmet needs, in
particular focusing on autoimmune and infectious diseases. Prof.
Vorup-Jensen is on the editorial boards of Frontiers in
Pharmacology, Frontiers in Immunology, and Molecular and Cellular
Therapies. Prof. Vorup-Jensen was recently elected member of The
Danish Academy of Natural Sciences.
“This engrossing book is devoted to nanomedicine, one of the fastest-growing and revolutionary branches of healthcare. … The book Nanomedicine provides a well-done and up-to-date review of hot topics in the field of nanomedicine and gives insight to this exciting interdisciplinary subject.” (Alena Gabelova, Neoplasma, Vol. 64 (2), 2017)
|
Ask a Question About this Product More... |
|
